Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 2,523

Document Document Title
WO/2009/111037A2
The disclosures herein provide lipoic acid salts, as well as polymorphs, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administrat...  
WO/2009/104717A1
Provided is a polymer compound that is a photoresist composition able to form photoresist films having excellent acid reactivity and thermal stability, minimal swelling during development, and a refractive index at a 193 nm wavelength of...  
WO/2009/104726A1
Disclosed is a polymerizable compound represented by the formula, which is useful as a raw material for a polymer compound which experiences little swelling during development. Also disclosed are a polymer compound obtained by polymerizi...  
WO/2009/104727A1
Disclosed is a method for producing an acrylate derivative represented by the formula, which can be a raw material for a polymer compound for obtaining a photoresist composition which can be formed into and patterned as a photoresist fil...  
WO/2008/110612A8
The present invention provides novel compounds which contain no zinc or phosphorus components for use in lubricating compositions, e.g. for replacing ZnDTP. To this end the present invention provides a compound having the general formula...  
WO/2009/102039A1
Disclosed is, for example, a compound that can be a material which can control many functions. According to a first aspect of the present invention, there is provided an organic semiconductor compound characterized in that the organic se...  
WO/2009/065926A3
The present invention relates to new polysulf urated compounds containing 2 or more sulphur atoms belonging to the class of organic thiosulf onates, or dithiole-thione derivatives cyclic or linear, or trithiocarbonates for the use alone ...  
WO/2009/086547A1
The present invention is directed to multiple a-lipoic acid-containing hydrophobic compounds (mALAs) capable of acting as scavengers of free radicals, metals and reactive oxygen species (ROS). Methods of synthesizing novel antioxidant mA...  
WO/2009/078366A1
Disclosed is a stable α-lipoic acid. Also disclosed is a method for producing α-lipoic acid nanoparticles, which comprises a step of preparing an aqueous dispersion liquid containing α-lipoic acid and a nonionic surfactant; a step of ...  
WO/2009/074733A2
The invention relates to compounds of the formula (I) in which A is an angiotensine-converting enzyme inhibitor including at least one salifiable basic function, B is a compound including at least one acidic sailifiable function and at l...  
WO/2009/065926A2
The present invention relates to new polysulf urated compounds containing 2 or more sulphur atoms belonging to the class of organic thiosulf onates, or dithiole-thione derivatives cyclic or linear, or trithiocarbonates for the use alone ...  
WO/2009/062332A2
A method of providing a cooling sensation to the skin or the mucous membranes of the body, comprising the application thereto of at least one compound of the Formula (I) in which R1 is selected from H and OMe, R2 is selected from OH, OMe...  
WO/2009/023160A3
The present disclosure describes novel small-molecule inhibitors of bacterial sortases. The identified inhibitors may be used in the methods of treatment and prevention described in the present disclosure.  
WO/2009/047043A1
The present invention relates to co-crystals of pyrimethanil and dithianon, which, in a X-ray powder diffractogram at 25°C show at least three of the following reflexes: 2θ = 7.46 ± 0.20, 2θ = 9.98 ± 0.20, 2θ = 13.28 ± 0.20, 2θ =...  
WO/2009/014267A3
There is provided a compound having an excellent controlling effect on arthropod pests represented by the formula (I-1): wherein Z represents an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; G ...  
WO/2009/034457A1
Compounds having a general formula (I) are used for the treatment of neurodegenerative diseases, wherein at least one of R1 ed R8 is chosen from the group consisting of (II), (III), (V), (VI), (XVII).  
WO/2009/026837A1
The present invention belongs to the technical filed of medicine, and relates to derivatives of 4,5-disubstituted phenyl-3H-1,2-dithiole-3-thione, -one, -ketoxime, which have the formula as follows: X is represented as S, O, N-OR, wherei...  
WO/2009/005110A3
There is provided a halogen-containing organosulfur compound having an excellent controlling effect on arthropod pests represented by the formula (I): wherein, m represents 0, 1 or 2, n represents 0, 1 or 2, A represents optionally subst...  
WO/2008/120070A3
The invention relates to medicine and chemical and pharmaceutical industry, and more particularly to a new physiologically active substance 2(hydroxyethyl)trimethylammonium thioctate (choline thioctate) displaying hepatoprotective, hypoa...  
WO/2008/151515A1
(5-(p-hydroxyphenyl)-1,2-dithiacyclopent-4-ene-3-thione) fibrate carboxylate compounds represented by general formula (I). Pharmaceutical compositions containing anyone of aforementioned compounds. The uses of aforementioned compounds in...  
WO/2008/110612A3
The present invention provides novel compounds which contain no zinc or phosphorus components for use in lubricating compositions, e.g. for replacing ZnDTP. To this end the present invention provides a compound having the general formula...  
WO/2008/054675A3
Diaryl ethers in which one of the aryl groups is a phenyl fused to a cycloalkyl or heterocyclic ring, to which is attached an acetic acid group, are agonists of G-protein coupled receptor 40 (GPR40) and are useful as therapeutic compound...  
WO/2008/120070A2
The invention relates to medicine and chemical and pharmaceutical industry, and more particularly to a new physiologically active substance 2(hydroxyethyl)trimethylammonium thioctate (choline thioctate) displaying hepatoprotective, hypoa...  
WO/2008/110612A2
The present invention provides novel compounds which contain no zinc or phosphorus components for use in lubricating compositions, e.g. for replacing ZnDTP. To this end the present invention provides a compound having the general formula...  
WO/2008/106640A1
The present invention describes polymers containing 1,2-dithiolanes capable of acting as scavengers of free radicals, metals and reactive oxygen species. Also described are methods of synthesizing the antioxidant 1,2-dithiolane derivativ...  
WO/2008/081017A1
A compound of general formula (I). A process for preparing this compound. A fungicidal composition comprising a compound of general formula (I). A method for treating plants by applying a compound of general formula (I) or a composition ...  
WO/2008/072794A1
A compound of formula (1): wherein A1 and A2 are -O-, -NR-, -S-, or -CO-, in which R is a hydrogen atom or substituent; Z is one or two atoms selected from a carbon atom or a non-metal atom of Group 14, 15 or 16 in the Periodic Table, an...  
WO/2008/071980A1
There are described compounds of general formula (I) and isomeric forms thereof wherein n is 0,1,2 or 3, saturated or unsaturated; most preferably at least one of R1 to R5 represents halogen; at least one of R1, R2, R3, R4 and R5 is sele...  
WO/2008/062830A1
Disclosed is a novel spiroquinone derivative having high ABCA1 stabilization effect, which is useful as an agent for prevention and/or treatment of various diseases accompanied by hypoHDLemia. Specifically disclosed is a compound represe...  
WO/2008/052288A1
A compound of formula (I) wherein: R1 and R2 are the same or different and are independently selected from H and a shielding group; X and Y are each independently selected from N and CH; R3 is hydroxy, alkoxy, acyloxy or an ester group; ...  
WO/2008/009127A1
The present invention relates to derivatives of non-steroidal anti-inflammatory drugs (NSAIDs) having improved anti-inflammatory properties useful in the treatment of inflammation, pain and fever. More particularly, NSAIDs are derivatize...  
WO/2007/149313A1
Described herein is a compound of Formula (I), which is the metformin salt of the naturally occurring endogenous biological compound, (R)-(+) α lipoic acid, pharmaceutical compositions containing the compound of Formula (I), and methods...  
WO/2007/140611A1
Unique salts of trimebutine and N-monodesmethyl trimebutine, and their corresponding stereoisomers, having improved analgesic properties useful in the treatment of visceral pain are provided. The salts of the present invention are partic...  
WO/2007/095117A3
The invention provides a method for reducing esophageal irritation associated with alpha-lipoic acid upon oral administration through the use of the trometamol salt of alpha-lipoic acid. The present invention also provides for the increa...  
WO/2007/104959A1
Compounds of formula (I) are active as dopaminergic compounds or as compounds which or as compounds which diminish the symptoms of dopamine deficiency.: wherein: R1 and R2 are independently selected from -C(=O)R5 or -C(=O)OR5; or one of ...  
WO/2007/105854A1
The present invention relates to derivatives of lipoic acid and skin external applications containing thereof that represent whitening effect, soothing effect, anti-aging effect and acne- improving effect and preventing effects of bladne...  
WO/2007/095760A1
The invention includes novel compounds, including but not limited to formula A and formula B, and an improved delivery method. These compounds and methods are useful in preventing or treating diseases or conditions associated with or cau...  
WO/2007/097719A1
The present invention relates to a cyclisation process of forming a multiple ring compound from an isoprenoid compound. The cyclisation process involves reacting the isoprenoid compound with an acetal initiator under conditions sufficien...  
WO/2007/095117A2
The invention provides a method for reducing esophageal irritation associated with alpha-lipoic acid upon oral administration through the use of the trometamol salt of alpha-lipoic acid. The present invention also provides for the increa...  
WO/2007/091716A1
An optical film, which has been subjected to an orientation treatment, containing a low-molecular weight compound, in which a birefringence Δn(550 nm) is larger than zero (0) in an orientation direction, and the optical film satisfies t...  
WO/2007/068745A1
The invention concerns novel polyunsaturated compounds of formula (I) wherein: R1 represents a R'1, -A-R'1 group, R'1 being selected among - COOH, -COOR3, -CONH2, -CONHR3, -CONR3 R4, -CHO, -CH2OH, -CH2OR5, and A represents a C2-C16 alkyl...  
WO2006119758B1
The invention relates to dihydroxyphenylalanine derivatives, the production thereof, and pharmaceutical compositions containing said dihydroxyphenylalanine derivatives. The invention further relates to the use of said dihydroxyphenylalan...  
WO/2007/049736A1
This invention provides a process for producing a natural product having stable quality with high recovery. There is also provided a method for concentration-crystallizing a natural product, characterized by comprising continuously measu...  
WO/2007/049658A1
A dithianedithiol derivative represented by the following general formula (1): (wherein R represents hydrogen or acyl; and X represents a C1-12 divalent hydrocarbon group which may have a substituent not participating in reactions and ma...  
WO/2007/035735A1
The invention features compositions comprising at least one monomer that comprises a cyclic dithiane moiety attached to a (meth)acryloyl moiety. The composition may optionally contain additional polymerizable compounds, such as ethylenic...  
WO/2007/032362A1
It is intended to provide a substituted cycloalkene derivative represented by the general formula (I) which has an action of suppressing intracellular signal transduction or cell activation caused by endotoxin and a cell response such as...  
WO/2006/119758A3
The invention relates to dihydroxyphenylalanine derivatives, the production thereof, and pharmaceutical compositions containing said dihydroxyphenylalanine derivatives. The invention further relates to the use of said dihydroxyphenylalan...  
WO/2007/015412A1
Disclosed is an organic electroluminescent device (organic EL device) of simple structure which is improved in luminous efficiency and sufficiently secured in driving stability. Also disclosed is a heterocyclic compound used for such an ...  
WO/2006/134282A1
The invention concerns a cosmetic, therapeutic, in particular dermatological, bioprecursor of formula [A]n -PP - [B]m wherein: PP represents a polyphenol radical where each hydroxyl function is protected by a group A or a group B; A is a...  
WO/2006/134489A1
The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) derivatives of sulindac, for the treatment/prevention, alone or in combination, of cancer.  

Matches 151 - 200 out of 2,523